These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20347009)

  • 21. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice.
    Xu B; Ho Y; Fasolino M; Medina J; O'Brien WT; Lamonica JM; Nugent E; Brodkin ES; Fuccillo MV; Bucan M; Zhou Z
    PLoS Genet; 2023 Feb; 19(2):e1010659. PubMed ID: 36848371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
    Lett TA; Tiwari AK; Meltzer HY; Lieberman JA; Potkin SG; Voineskos AN; Kennedy JL; Müller DJ
    Schizophr Res; 2011 Nov; 132(2-3):121-4. PubMed ID: 21890328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
    Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
    Møller RS; Weber YG; Klitten LL; Trucks H; Muhle H; Kunz WS; Mefford HC; Franke A; Kautza M; Wolf P; Dennig D; Schreiber S; Rückert IM; Wichmann HE; Ernst JP; Schurmann C; Grabe HJ; Tommerup N; Stephani U; Lerche H; Hjalgrim H; Helbig I; Sander T;
    Epilepsia; 2013 Feb; 54(2):256-64. PubMed ID: 23294455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.
    Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T
    Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in SNAP29 gene promoter region associated with schizophrenia.
    Saito T; Guan F; Papolos DF; Rajouria N; Fann CS; Lachman HM
    Mol Psychiatry; 2001 Mar; 6(2):193-201. PubMed ID: 11317222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare heterozygous genetic variants of NRXN and NLGN gene families involved in synaptic function and their association with neurodevelopmental disorders.
    Gerik-Celebi HB; Bolat H; Unsel-Bolat G
    Dev Neurobiol; 2024 Jul; 84(3):158-168. PubMed ID: 38739110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs.
    Chen X; Shen Y; Zhang F; Chiang C; Pillalamarri V; Blumenthal I; Talkowski M; Wu BL; Gusella JF
    Am J Hum Genet; 2013 Mar; 92(3):375-86. PubMed ID: 23472757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.
    Huang AY; Yu D; Davis LK; Sul JH; Tsetsos F; Ramensky V; Zelaya I; Ramos EM; Osiecki L; Chen JA; McGrath LM; Illmann C; Sandor P; Barr CL; Grados M; Singer HS; Nöthen MM; Hebebrand J; King RA; Dion Y; Rouleau G; Budman CL; Depienne C; Worbe Y; Hartmann A; Müller-Vahl KR; Stuhrmann M; Aschauer H; Stamenkovic M; Schloegelhofer M; Konstantinidis A; Lyon GJ; McMahon WM; Barta C; Tarnok Z; Nagy P; Batterson JR; Rizzo R; Cath DC; Wolanczyk T; Berlin C; Malaty IA; Okun MS; Woods DW; Rees E; Pato CN; Pato MT; Knowles JA; Posthuma D; Pauls DL; Cox NJ; Neale BM; Freimer NB; Paschou P; Mathews CA; Scharf JM; Coppola G; ;
    Neuron; 2017 Jun; 94(6):1101-1111.e7. PubMed ID: 28641109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a single nucleotide polymorphism at the 5' promoter region of human reelin gene and association study with schizophrenia.
    Chen ML; Chen SY; Huang CH; Chen CH
    Mol Psychiatry; 2002; 7(5):447-8. PubMed ID: 12082559
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese.
    Sato N; Kageyama S; Chen R; Suzuki M; Tanioka F; Kamo T; Shinmura K; Nozawa A; Sugimura H
    Psychiatr Genet; 2010 Jun; 20(3):135-6. PubMed ID: 20414139
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
    Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
    PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.
    Dachtler J; Ivorra JL; Rowland TE; Lever C; Rodgers RJ; Clapcote SJ
    Behav Neurosci; 2015 Dec; 129(6):765-76. PubMed ID: 26595880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
    Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
    Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of rare copy number variants in high burden schizophrenia families.
    Van Den Bossche MJ; Strazisar M; Cammaerts S; Liekens AM; Vandeweyer G; Depreeuw V; Mattheijssens M; Lenaerts AS; De Zutter S; De Rijk P; Sabbe B; Del-Favero J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Apr; 162B(3):273-82. PubMed ID: 23505263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.